Pfizer Fights Parkinson's Disease Together With IBM

f:id:evabrain:20160413004413j:plain

Pfizer partners up with IBM to research and develop solutions for the Parkinson's disease

Pfizer is collaborating with IBM to research on symptoms and cures for the Parkinson’s disease. The combination of a tech organization with a drug making company might just end up making wonders. Technology will help enable using sensor and different innovative ways to explore the life taking disease. The medicinal giant is hoping to develop a sensory remote that will monitor the patient’s body in its place by 2019.

The pharmaceutical company is not sticking to the old-fashioned way of researching the Parkinson’s disease but is taking the help of the latest tech as it aims to build sensor system. The plan is to build this sensory system by 2019, which is going to be Phase III of the disease’s trial. Researchers will now have the help of mobile phone, sensors, and other technology to explore the disease and monitor the patients’ health via real time.

Parkinson’s symptoms are difficult to diagnose in patients as they vary from one individual to another every day, while doctors are only able to see the patients on a periodic basis. Thus, this collaboration and research has become necessary. Pfizer Inc. and IBM will be gathering the essential data regarding the patients’ health and activities in the body such as sleep and cognition.

Doctor usually gathers data through the patients and what they tell them, which can be problematic sometimes as the accuracy in this method is questionable. Once everything is computerized, the accuracy of the data will be efficient enough to make a valid analysis.  

The system, once constructed, is going to be tested by the US drug maker in a clinical environment in order to attain the necessary approvals for the usage of the developed product commercially. These partnered up parties are planning to get the clinical trial to begin by 2018, once the approvals are received, the system can be tweaked and analyze other diseases too including epilepsy. This partnership sets the biggest example of improving IoT each day.

IoT will change the way we lead our lives in the future for our workspace to our homes and even when it comes to how we travel and do other extracurricular activities. Everything will become easier to connect and be easier to access at a click away from our fingers. As we grow and move forward into a new era, so do diseases with us, thus the development and research on diseases is vital.

Pfizer will be able to a difference in the lives of the patients who are never given a proper diagnosis of what they really have, and the Parkinson’s disease will become easier to diagnose with the help of the right technology.